2-Aryl-4-morpholinothieno[3,2-d]pyrimidines are known PI3K inhibitors. This class of compounds also potently inhibited the homologous enzyme mTOR. Replacement of the morpholine group in these compounds with an 8-oxa-3-azabicyclo[3.2.1]octane group led to mTOR inhibitors with selectivity over PI3K. Optimization of the 2-aryl substituent led to the discovery of 2-(4-ureidophenyl)-thienopyrimidines as highly potent (IC(50) <1nM) mTOR inhibitors with excellent selectivity (up to >1000-fold) over PI3K and good potency in a cellular proliferation assay (IC(50) <50nM).

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2009.10.075DOI Listing

Publication Analysis

Top Keywords

selectivity pi3k
8
discovery 2-arylthieno[32-d]pyrimidines
4
2-arylthieno[32-d]pyrimidines 8-oxa-3-azabi-cyclo[321]octane
4
8-oxa-3-azabi-cyclo[321]octane 4-position
4
4-position potent
4
potent inhibitors
4
inhibitors mtor
4
mtor selectivity
4
pi3k
4
pi3k 2-aryl-4-morpholinothieno[32-d]pyrimidines
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!